James de Lemos

About James de Lemos

James de Lemos, With an exceptional h-index of 120 and a recent h-index of 71 (since 2020), a distinguished researcher at University of Texas Southwestern Medical Center, specializes in the field of Cardiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Survival Characteristics of Older Patients Hospitalized With COVID-19: Insights From the American Heart Association COVID-19 Cardiovascular Disease Registry

Associations between cardiac function and brain health in diverse middle-aged adults: the Dallas heart study-2

High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT)

Recognized Outstanding Reviewers for Circulation in 2023

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT

Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study

AMBULATORY SHOCK?: MANAGEMENT AND LONG-TERM OUTCOMES AMONG OUTPATIENTS WITH SEVERELY REDUCED CARDIAC INDEX

James de Lemos Information

University

Position

___

Citations(all)

105902

Citations(since 2020)

41782

Cited By

79541

hIndex(all)

120

hIndex(since 2020)

71

i10Index(all)

448

i10Index(since 2020)

319

Email

University Profile Page

Google Scholar

James de Lemos Skills & Research Interests

Cardiology

Top articles of James de Lemos

Survival Characteristics of Older Patients Hospitalized With COVID-19: Insights From the American Heart Association COVID-19 Cardiovascular Disease Registry

Journal of the American Medical Directors Association

2024/2

Associations between cardiac function and brain health in diverse middle-aged adults: the Dallas heart study-2

JACC: Advances

2024/2/1

High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT)

Clinical Chemistry

2024/2

Recognized Outstanding Reviewers for Circulation in 2023

2024/1/30

Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT

American Journal of Kidney Diseases

2024/5/1

Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study

Mayo Clinic Proceedings

2024/4/26

AMBULATORY SHOCK?: MANAGEMENT AND LONG-TERM OUTCOMES AMONG OUTPATIENTS WITH SEVERELY REDUCED CARDIAC INDEX

Journal of the American College of Cardiology

2024/4/2

SOCIAL VULNERABILITY AND LONG-TERM CARDIOVASCULAR OUTCOMES AMONG PATIENTS HOSPITALIZED WITH COVID-19

Journal of the American College of Cardiology

2024/4/2

LONG-TERM OUTCOMES AND MEDICAL THERAPY AMONG PATIENTS WITH CARDIOGENIC SHOCK TREATED IN A SAFETY NET HOSPITAL

Journal of the American College of Cardiology

2024/4/2

Chest Pain in the Emergency Department: Chasing Perfection

2024/4/2

Characteristics and Outcomes of Patients Receiving Advanced Heart Failure Therapies from a Safety-Net Hospital in the United States

Blood

2019/11/13

Associations of ambulatory blood pressure measurements with high-sensitivity troponin and natriuretic peptide levels in SPRINT

American Journal of Hypertension

2024/3/30

Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT

Journal of the American Heart Association

2024/3/19

Variation of NT-proBNP and High-Sensitivity Cardiac Troponin T Across Levels of Estimated Glomerular Filtration Rate: The SPRINT Trial

Circulation

2024/3/19

Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I TTR carriers in the general population

Amyloid

2024/3/6

Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort

Atherosclerosis

2024/3/1

National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis

Cardiovascular Interventions

2024/2/26

Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m2: SURMOUNT-1 Ambulatory Blood Pressure Monitoring …

Hypertension

2024/2

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

American heart journal

2023/4/1

James De Lemos
James De Lemos

H-Index: 74

See List of Professors in James de Lemos University(University of Texas Southwestern Medical Center)

Co-Authors

academic-engine